Ahpra registration PHY0002298174
How these guides are written and reviewed →
People who survive a serious stay in intensive care often come out remarkably weak — not just tired, but genuinely unable to lift their arms, stand, or grip a cup. This is ICU-acquired weakness. It happens because muscle wastes extraordinarily quickly during critical illness, and because the nerves supplying muscle can also be affected. It is not simply a matter of being out of condition, and it does not resolve in a week. Many survivors also have problems with memory, concentration and mood afterwards — together these are called post-intensive care syndrome. Rehabilitation, started early and continued long after discharge, is the treatment. This page explains what happens, why, and what helps.
Definition
ICU-acquired weakness is clinically detectable, generalised, symmetrical limb weakness developing during critical illness with no plausible cause other than the critical illness itself. It is usually diffuse and flaccid, affects proximal muscles more than distal, spares the face, and frequently involves the diaphragm. Three overlapping entities sit beneath the label: critical illness polyneuropathy (an axonal sensorimotor neuropathy), critical illness myopathy (a primary muscle disorder, generally with better recovery), and critical illness neuromyopathy where both coexist — which is the commonest.1
Post-intensive care syndrome is the broader concept: new or worsening impairment in physical, cognitive or mental health after critical illness, persisting beyond the acute hospital stay, and affecting family members as well as patients.2
Pathophysiology
Muscle wasting in critical illness
Muscle loss in critical illness is fast and severe. Serial measurement in a landmark observational study showed rectus femoris cross-sectional area fell by around 10% in the first week, with greater loss in patients with multi-organ failure — wasting that would take months of ordinary bed rest to achieve.3 The mechanism is not simple disuse. Systemic inflammation, sepsis and immobility drive a marked imbalance between muscle protein breakdown and synthesis; mitochondrial dysfunction impairs energy production within the myocyte; and neuromuscular blocking agents, corticosteroids and prolonged deep sedation each add insult. Loss of contractile quality compounds loss of bulk, so strength falls faster than cross-sectional area alone predicts.
Nerve involvement
In parallel, microvascular changes, hyperglycaemia, and inflammatory mediators damage peripheral nerve axons, producing a distal axonal degeneration that is slower to recover than muscle. Where neuropathy predominates, sensory loss accompanies the weakness and the recovery horizon lengthens considerably — which is why distinguishing the two matters prognostically even though it rarely changes acute management.
The diaphragm
The diaphragm is affected in parallel and often faster than the limbs. Ventilator-induced diaphragm dysfunction — measurable thinning and weakness within days of controlled mechanical ventilation — contributes to weaning failure and prolongs ventilation, which in turn prolongs immobility. The result is a self-reinforcing cycle: weakness delays weaning, delayed weaning deepens weakness.4
Co-morbidities and contributors
- Sepsis and multi-organ failure — the strongest single association.
- Prolonged mechanical ventilation and deep sedation — both duration-dependent.
- Hyperglycaemia and prolonged systemic corticosteroids.
- Neuromuscular blocking agents, particularly with concurrent corticosteroids.
- Pre-existing frailty, sarcopenia and older age — less reserve to lose.
- Undernutrition during and after the ICU stay, when appetite is poor and requirements are high.
- Delirium — interacts with immobility in both directions and predicts long-term cognitive impairment.
Prevalence
Clinically detectable weakness affects roughly a quarter to a half of patients ventilated for a week or more, and considerably more in those with sepsis or multi-organ failure. Around a quarter of survivors of prolonged ventilation still have significant weakness at hospital discharge, and a substantial minority report persistent physical limitation at one year. Functional impairment is common even in patients who look to have recovered: survivors of acute respiratory distress syndrome in a landmark Canadian cohort had persistently reduced six-minute walk distance and physical quality of life five years after discharge, with muscle weakness and wasting the dominant complaint rather than lung function.5
Causes and risk factors
Risk accumulates with the duration and severity of critical illness rather than arising from a single cause. The practically modifiable factors are the ones that shape ICU practice: minimising sedation depth and duration, avoiding unnecessary neuromuscular blockade, controlling hyperglycaemia, treating sepsis promptly, attending to nutrition, and — the physiotherapy contribution — reducing time spent immobile. Framed the other way round, this is a condition substantially produced by the treatment environment, which is precisely why it is worth systematic prevention effort.
Symptoms
Limb weakness
Symmetrical, predominantly proximal weakness, often first noticed as inability to lift the arms off the bed, hold the head up, or sit unsupported. Reduced or absent deep tendon reflexes are usual, with sensory loss where neuropathy predominates. The face is spared, which helps distinguish it from myasthenia and brainstem pathology.
Respiratory muscle involvement
Difficulty weaning from the ventilator, rapid shallow breathing, paradoxical abdominal movement, and a weak cough with recurrent atelectasis and sputum retention from diaphragm and expiratory muscle weakness. This is frequently the presenting problem rather than the limb weakness.
Fatigue and function
Profound fatigue disproportionate to activity, persisting for months, and loss of independence in basic tasks — standing, transferring, walking, washing, dressing. Patients commonly describe exhaustion after activities that appear trivial from the outside, which is a source of considerable misunderstanding at home.
Cognitive and psychological features
Frequently accompanied by impaired attention, memory and executive function, low mood, anxiety and post-traumatic symptoms — part of the wider post-intensive care syndrome and a major determinant of whether physical rehabilitation succeeds.2
Diagnosis
Why diagnosis matters
Naming the problem changes management. It separates generalised critical-illness weakness from a focal neurological event, a spinal cord lesion, Guillain–Barré syndrome, myasthenia or a drug effect — each of which needs a different response. It also legitimises the patient's experience and justifies a rehabilitation pathway that would otherwise be omitted.
How is it diagnosed?
Clinically, using the Medical Research Council sum score across six muscle groups bilaterally: a score below 48 out of 60 in an awake, cooperative patient defines ICU-acquired weakness. Handgrip dynamometry is a quicker screen. Both require the patient to be alert enough to cooperate, which is often the limiting factor and the reason diagnosis is frequently delayed until sedation lightens.1
Ultrasound
Muscle ultrasound quantifies wasting and can be used serially, including in unconscious patients, which is its main advantage over volitional testing.3 Diaphragm ultrasound assesses thickness and thickening fraction and is useful in weaning difficulty.4
Electrophysiology and biopsy
Nerve conduction studies and electromyography distinguish neuropathy from myopathy where the picture is unclear or recovery is unexpectedly poor. Muscle biopsy is reserved for genuine diagnostic uncertainty, and neither is required in the typical case.
Investigations for related conditions
Glucose, electrolytes including phosphate and magnesium, thyroid and creatine kinase are checked, along with a medication review for neuromuscular blockers, corticosteroids and aminoglycosides. Neuroimaging is used where the deficit is asymmetrical or a central cause is possible, and delirium and cognition are screened formally rather than by impression.
Management
Management and goals
The goals are to prevent weakness developing, limit its severity where it does, restore ventilatory independence, rebuild strength and function over a horizon of months, and support the cognitive and psychological recovery without which physical gains are not converted into life. Management spans three settings — ICU, ward, community — and handover between them is where recovery is most often lost.
Prevention comes first
Nothing treats established weakness as effectively as preventing it. The ABCDEF bundle — assess and manage pain, both spontaneous awakening and breathing trials, choice of sedation, delirium monitoring, early mobility and exercise, and family engagement — is associated with dose-dependent improvements in survival, delirium and mechanical ventilation duration across a very large cohort.6
Early mobilisation
Early physical and occupational therapy delivered during periods of sedation interruption improved return to independent function at hospital discharge, shortened delirium and reduced ventilator days in the landmark randomised trial.7 It is feasible and safe in ventilated patients, including those on vasoactive support, when delivered against agreed safety criteria.8
Dose and timing
More is not automatically better. A large multicentre trial of increased early mobilisation in ventilated patients found no improvement in days alive and out of hospital compared with usual care, and more adverse events in the intervention group — a caution against escalating dose indiscriminately and an argument for targeted, individualised prescription.9
Adjuncts
Neuromuscular electrical stimulation is used where volitional exercise is impossible, with modest and inconsistent evidence. In-bed cycle ergometry extends what is possible for sedated patients. Inspiratory muscle training has been used in weaning difficulty. Nutrition matters, though aggressive early feeding does not prevent wasting and may not help — adequate protein through the recovery phase appears to matter more than calories in the acute phase.
Identifying deterioration
After the ICU
Recovery continues long after discharge, and the ward and community phases are where much of the functional gain occurs. Notably, trials of generic post-hospital rehabilitation programmes have been largely negative for improving physical outcomes at six months, which suggests the answer is not a standard programme but an individualised, longer-horizon one.10
Multi-system manifestations
Respiratory muscles and weaning
Diaphragm and expiratory muscle weakness prolongs ventilation, weakens cough, causes sputum retention and atelectasis, and raises the risk of extubation failure and pneumonia. It is the manifestation with the most immediate consequences and the one most responsive to physiotherapy.
Swallowing and voice
Post-extubation dysphagia is common after prolonged intubation, from a combination of laryngeal injury, sensory impairment and generalised weakness, and carries aspiration risk. Voice change and vocal fatigue frequently accompany it and affect communication at exactly the point the patient most needs to be heard.
Cognition
New long-term cognitive impairment affects attention, memory and executive function, is associated with the duration of delirium, and can resemble mild dementia in patients who were previously working. It directly limits the ability to follow a home exercise programme, which is a practical rehabilitation problem rather than a separate issue.
Mental health
Anxiety, depression and post-traumatic stress symptoms are all substantially more common after critical illness, often triggered by delirium memories, and are strongly associated with worse physical recovery. Family members show comparable rates.2
Joints, skin and contractures
Joint contractures from prolonged positioning, shoulder pain, heterotopic ossification, pressure injuries and neuropathic pain all limit rehabilitation and are largely preventable with early positioning and range-of-movement work.
Cardiovascular deconditioning
Reduced stroke volume, orthostatic intolerance and markedly reduced peak oxygen uptake persist well beyond discharge, so breathlessness and tachycardia on minimal effort are frequently deconditioning rather than new cardiac or respiratory disease — a distinction worth making explicitly before it drives further investigation and further rest.
Living with ICU-acquired weakness
Recovery is measured in months to years, not weeks, and the trajectory is rarely linear. Patients commonly describe being discharged looking well and then discovering they cannot climb their own stairs.
Fatigue and pacing
Fatigue is disproportionate, unpredictable and the symptom patients find hardest to explain to others. Activity pacing, planning the day around a limited energy budget, and accepting a non-linear course prevent the boom-and-bust cycle that stalls progress.
Nutrition
Appetite is poor exactly when protein requirements are highest, and weight regained is often fat rather than muscle unless resistance exercise accompanies it. Dietetic input through the recovery phase, not just the ICU stay, is worth arranging.
Sleep
Sleep is commonly fragmented and unrefreshing for months, disturbed by nightmares, altered circadian rhythm and deconditioning. Poor sleep amplifies fatigue, pain and low mood, so it is treated as part of rehabilitation rather than a side issue.
Return to work and driving
Return to work is delayed and sometimes not achieved; financial and relationship strain follows. Graded return, workplace adjustment and honest discussion of cognitive as well as physical capacity all help. Driving needs reassessment where strength, reaction time or cognition are affected.
Family and carers
Family members carry a substantial burden of their own, with anxiety, depression and post-traumatic symptoms well described, and they are frequently doing the care and the pacing negotiation. Including them in education and goal-setting improves both their outcomes and the patient's.
Follow-up and peer support
ICU follow-up clinics, where they exist, provide explanation, screening and coordination that primary care is not resourced to deliver. Peer support — meeting other survivors — addresses the isolation of an illness few people around the patient understand. Practical support with graded goals, equipment, pacing and honest expectations matters as much as the exercise prescription.
Prognosis
Myopathy-predominant weakness generally recovers better and faster than neuropathy-predominant weakness, which may leave permanent deficit. Most survivors improve substantially over the first six to twelve months, but a significant proportion do not return to their previous functional level: five-year follow-up of ARDS survivors showed persisting exercise limitation and reduced physical quality of life, driven by muscle wasting and weakness rather than pulmonary impairment.5 Older age, pre-existing frailty, longer ICU stay, sepsis and coexisting cognitive impairment all predict poorer recovery.
Role of the physiotherapist
This is a condition largely created in hospital and largely mitigated by physiotherapy. In the ICU the role is to make mobilisation happen — negotiating sedation and lines, applying safety criteria, and getting patients sitting, standing and stepping days earlier than would happen by default — alongside respiratory care, weaning support, positioning and range-of-movement work to prevent contracture.
On the ward the task shifts to rebuilding strength, balance and endurance in someone who tires within minutes, and to setting expectations that recovery will take months rather than weeks. Progressive resistance work, sit-to-stand practice, gait retraining, and cardiorespiratory reconditioning are the substance of it, with cough strength and sputum clearance monitored while respiratory muscles remain weak.
In the community it is long-horizon rehabilitation: progressive strength work, cardiovascular reconditioning, fatigue management and pacing, and the return-to-life goals that matter to the patient. Throughout, the physiotherapist is often the clinician who explains what happened to the patient's body — which is, for many survivors, the first time anyone has.
Part 1 · References
- Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37(10 Suppl):S299–S308.
- Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med 2012;40(2):502–509.
- Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013;310(15):1591–1600.
- Goligher EC, Dres M, Fan E, et al. Mechanical ventilation-induced diaphragm atrophy strongly impacts clinical outcomes. Am J Respir Crit Care Med 2018;197(2):204–213.
- Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364(14):1293–1304.
- Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for critically ill patients with the ABCDEF bundle: results of the ICU Liberation Collaborative in over 15,000 adults. Crit Care Med 2019;47(1):3–14.
- Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373(9678):1874–1882.
- Hodgson CL, Stiller K, Needham DM, et al. Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults. Crit Care 2014;18(6):658.
- TEAM Study Investigators and the ANZICS Clinical Trials Group. Early active mobilization during mechanical ventilation in the ICU. N Engl J Med 2022;387(19):1747–1758.
- Cuthbertson BH, Rattray J, Campbell MK, et al. The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ 2009;339:b3723.
References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.
More than one of our services applies here, and which combination suits you depends on what your assessment shows.
Clinical evidence
Part 1 covers the same condition without the technical detail. What follows is the evidence base behind it, written for clinicians — the literature, the reasoning and the gaps.
For clinicians: this summary supports clinical reasoning and is not a protocol. Check current guidelines and local policy before applying it, and read it alongside the key references and guidelines directory.
Framing. ICU-acquired weakness is best understood as an iatrogenic-adjacent complication of critical illness in which the two most modifiable levers — sedation depth and immobility — are both partly within physiotherapy's influence. The evidence base has matured past "early mobilisation is good" into a more precise question: which patients, at what dose, at what point in the illness.1,2
Mechanism and measurement
- Muscle wasting is early and severe: rectus femoris cross-sectional area fell approximately 10% over seven days, greater with multi-organ failure, with protein degradation exceeding synthesis from day one.3
- Ventilator-induced diaphragm dysfunction develops within days of controlled ventilation and independently predicts weaning failure and prolonged ventilation — making diaphragm-sparing ventilation and spontaneous breathing trials part of the weakness conversation.4
- MRC sum score below 48/60 in a cooperative patient remains the diagnostic standard, with handgrip dynamometry as a screen; both require arousal, so muscle ultrasound is increasingly used in sedated patients.5
What works, and the limits
- Early physical and occupational therapy during sedation interruption improved return to independent functional status at discharge, reduced delirium duration and increased ventilator-free days.1
- The ABCDEF bundle shows a dose–response relationship with survival, delirium, coma, restraint use and ventilation duration across more than 15,000 patients — the strongest argument for embedding mobility in a bundle rather than delivering it in isolation.6
- More is not better. The TEAM trial found increased early mobilisation did not improve days alive and out of hospital at 180 days and was associated with more adverse events, principally cardiovascular and desaturation events.2
- Post-hospital generic rehabilitation programmes have largely failed to improve physical outcomes at six months in randomised trials, indicating that the effective intervention is not a standard package.7
- Safety criteria for active mobilisation of ventilated patients are published as an expert consensus traffic-light framework and should be the local operating standard.8
Physiotherapy implications
- Target the modifiable drivers, not just the muscle: advocate for lighter sedation, spontaneous breathing trials, delirium screening and avoidance of unnecessary neuromuscular blockade — these change weakness more than any exercise prescription.6
- Prescribe rather than protocolise. Titrate to physiological response and adverse-event risk; TEAM suggests indiscriminate dose escalation causes harm without benefit.2
- Use objective measures — MRC sum score, handgrip, functional milestone scales, muscle ultrasound where available — to demonstrate trajectory and justify continued rehabilitation resource.5
- Treat the diaphragm as a muscle: support weaning, consider inspiratory muscle training in protracted weaning, and recognise that a weak cough and recurrent atelectasis may be weakness rather than sputum load.4
- Screen for the non-physical domains — cognition, mood, post-traumatic symptoms — and refer, because physical rehabilitation alone does not address post-intensive care syndrome.9
- Plan a long horizon and hand over explicitly at each transition; the ward and community phases are where most functional gain accrues and where patients are most often lost to follow-up.
Clinical reasoning
- Distinguish generalised critical-illness weakness from focal neurology, spinal cord pathology, Guillain–Barré syndrome, myasthenia and drug effects — asymmetry, cranial nerve involvement or a sensory level should stop you and prompt referral.5
- Failure to wean in a patient with clear lungs is frequently neuromuscular rather than respiratory.4
- Recovery that plateaus early, or a neuropathy-predominant picture, predicts a longer and less complete course — adjust goals and expectations rather than intensity alone.10
- A patient who looks well at discharge is not recovered; functional testing, not appearance, should drive the community referral.
Evidence gaps
- Optimal dose, timing, intensity and modality of ICU rehabilitation remain undefined, and TEAM has made the dose question more rather than less open.2
- No reliable tool identifies which patients will benefit most from intensive rehabilitation, or which will be harmed by it.
- Effective post-discharge models are unestablished after a series of negative trials of generic programmes.7
- Neuromuscular electrical stimulation, cycle ergometry and inspiratory muscle training have small, heterogeneous and inconsistent evidence bases.
References for the clinical evidence summary
- Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373(9678):1874–1882.
- TEAM Study Investigators and the ANZICS Clinical Trials Group. Early active mobilization during mechanical ventilation in the ICU. N Engl J Med 2022;387(19):1747–1758.
- Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013;310(15):1591–1600.
- Goligher EC, Dres M, Fan E, et al. Mechanical ventilation-induced diaphragm atrophy strongly impacts clinical outcomes. Am J Respir Crit Care Med 2018;197(2):204–213.
- Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37(10 Suppl):S299–S308.
- Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for critically ill patients with the ABCDEF bundle: results of the ICU Liberation Collaborative in over 15,000 adults. Crit Care Med 2019;47(1):3–14.
- Cuthbertson BH, Rattray J, Campbell MK, et al. The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ 2009;339:b3723.
- Hodgson CL, Stiller K, Needham DM, et al. Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults. Crit Care 2014;18(6):658.
- Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med 2012;40(2):502–509.
- Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364(14):1293–1304.
Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.